News & Perspective

Jan 02, 2002

Jan 02, 2002

Anthrax vaccine option has few takers so far

Jan 2, 2001 (CIDRAP News) – Aside from Capitol Hill staff members, only 52 of more than 3,500 people who have been offered the anthrax vaccine because of the recent mail attacks have decided to take it, according to the Centers for Disease Control and Prevention (CDC).

Jan 07, 2002

Jan 07, 2002

New nuclear medicine technique shows promise for early diagnosis of anthrax

(CIDRAP News) – A new nuclear medicine technique using a radioisotope-labeled antibody has shown enough promise for early diagnosis of anthrax infection to gain the Food and Drug Administration's approval for a clinical trial, according to a recent report in the Journal of Nuclear Medicine.

Jan 09, 2002

Jan 09, 2002

FDA provides food industry with guidelines to prevent tampering

(CIDRAP News) – The Food and Drug Administration (FDA) has released two sets of guidelines designed to help food-related businesses of all kinds prevent food contamination and tampering by criminals or terrorists.

Jan 11, 2002

Jan 11, 2002

Five-state survey finds antibiotic-resistant enterococci in ground pork

(CIDRAP News) – A recent analysis of ground pork in grocery stores in five states showed that 4% of the samples contained enterococci with high-level resistance to gentamicin, an antibiotic used to treat enterococcal infections in humans. In addition, most Enterococcus faecium isolates were resistant to quinupristin-dalfopristin (Synercid), a streptogramin antibiotic used to treat infections caused by vancomycin-resistant E faecium.

Jan 11, 2002

Jan 11, 2002

CDC proposing to use immune globulin as treatment for severe anthrax

(CIDRAP News) – Federal health officials revealed this week that they are working on a plan to use immune globulin derived from the blood of anthrax-vaccinated military personnel for emergency treatment of patients with severe cases of inhalational anthrax, if needed.

Jan 14, 2002

Jan 14, 2002

Salmonellosis outbreak prompts new CDC warning about sprouts

(CIDRAP News) – Dozens of people in California and neighboring states contracted Salmonella infections from eating raw alfalfa sprouts last year in an episode that has prompted the Center for Disease Control and Prevention (CDC) to renew its warning that people with weak immune systems should not eat sprouts.

Jan 25, 2002

Jan 25, 2002

CDC to evaluate anthrax postexposure treatment through interviews

(CIDRAP News) – Thousands of people who were potentially exposed to anthrax last fall will be interviewed over the next 8 weeks to assess the results of their postexposure antibiotic treatment, the Centers for Disease Control and Prevention (CDC) announced yesterday.

Jan 28, 2002

Jan 28, 2002

HHS to release $200 million in bioterrorism preparedness funds to states

(CIDRAP News) – The US Department of Health and Human Services (HHS) will soon release about 20% of the $1 billion in bioterrorism preparedness funding that is slated to go to states this year, HHS Secretary Tommy G. Thompson announced Jan 25.

Jan 30, 2002

Jan 30, 2002

State health emergency laws aren't ready for bioterrorism, says expert

(CIDRAP News) – In view of the specter of bioterrorism, it's time to overhaul the hodgepodge of outdated, little-known, inconsistent state laws dealing with public health emergencies in the United States, an expert on the subject told a conference audience in Minneapolis yesterday.

Feb 01, 2002

Feb 01, 2002

FDA clears BioPort to distribute anthrax vaccine

(CIDRAP News) – BioPort Corp of Lansing, Mich., yesterday received Food and Drug Administration (FDA) approval to begin routine distribution of its anthrax vaccine after more than 3 years of effort to bring its operation up to federal standards.

"FDA is now satisfied that BioPort's renovated facility can produce a vaccine that meets FDA standards for safety and efficacy," the agency said in a news release.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»